logo

For the Inventor, By the Inventor

Sandwich, United Kingdom

John Paul Mathias

This inventor holds 31 USPTO granted patents and 1 published patent application, plus 2 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Pfizer Corporation, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Inc.. Active years: 2001-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Paul Mathias. Retrieved from https://idiyas.com/inventor/john-paul-mathias

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 67.7

 

Average Co-Inventor Count = 5.3

ph-index = 10

Forward Citations = 362(Granted Patents)


Location History:

  • Ashford, GB (2009)
  • Sandwich, GB (2001 - 2011)
  • Concord, MA (US) (2016 - 2023)

Company Filing History:

goldMedal25 out of 4,486 
 
Pfizer Corporation
 patents
silverMedal3 out of 4 
 
Cystic Fibrosis Foundation
 patents
bronzeMedal3 out of 5 
 
Cystic Fibrosis Foundation Therapeutics, Inc.
 patents

Years Active: 2001-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
CFTR Potentiators
PDE4 Inhibitors
Heterocyclic Compounds
Bicyclic Compounds
Triazolopyridinylsulfanyl Derivatives
Nicotinamide Derivatives
Pharmaceutically Active Compounds
P38 MAP Kinase Inhibitors
Pyrazolopyrimidinones
Quinazolinone Compounds
Therapeutic Compounds
31 patents (USPTO):Explore Patents
1. 11702424 - Bicyclic-fused heteroaryl or aryl compounds (2023-07-18),
2. 10793579 - Bicyclic-fused heteroaryl or aryl compounds (2020-10-06),
3. 10766904 - Bicyclic heteroaryl derivatives as CFTR potentiators (2020-09-08),
4. 10494374 - Pyrrolopyrimidines as CFTR potentiators (2019-12-03),
5. 10377762 - Bicyclic heteroaryl derivatives as CFTR potentiators (2019-08-13),
6. 10329302 - Bicyclic-fused heteroaryl or aryl compounds (2019-06-25),
7. 10316018 - Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators (2019-06-11),
8. 10308615 - Heterocyclic compounds as inhibitors of Vanin-1 enzyme (2019-06-04),
9. 10301315 - Pyrrolopyrimidines as CFTR potentiators (2019-05-28),
10. 10208053 - Bicyclic heteroaryl derivatives as CFTR potentiators (2019-02-19),
11. 10174000 - Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators (2019-01-08),
12. 10131670 - Bicyclic heteroaryl derivatives as CFTR potentiators (2018-11-20),
13. 9879022 - Bicyclic-fused heteroaryl or aryl compounds (2018-01-30),
14. 9458168 - Bicyclic-fused heteroaryl or aryl compounds (2016-10-04),
15. 8076356 - Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors (2011-12-13),

Title: John Paul Mathias - Innovator from Sandwich, GB

Introduction: John Paul Mathias is a renowned inventor hailing from Sandwich, Great Britain, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: John Paul Mathias holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, John Paul Mathias has worked with leading tech companies and research institutions, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, John Paul Mathias has collaborated with top scientists, engineers, and designers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: John Paul Mathias continues to be a driving force in the world of technology and innovation, with his relentless pursuit of excellence and passion for creating solutions that make a difference.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…